Competition

  • October 27, 2026

    FCC OKs Amazon's $11.6B Globalstar Satellite Buy

    The Federal Communications Commission has signed off on Amazon.com Inc.'s $11.6 billion plan to buy U.S. satellite company Globalstar Inc., bringing the e-commerce behemoth one step closer to expanding its nascent satellite internet business.

  • October 27, 2026

    5-Hour Energy Sellers Ask 9th Circ. To Revive Antitrust Fight

    Family-owned wholesalers urged the Ninth Circuit to revive antitrust claims Tuesday alleging 5-Hour Energy violated price discrimination law by providing Costco with disproportionate promotional support, arguing the court wrongly applied an "extremely narrow view of antitrust injury."

  • October 27, 2026

    AI Users Say SpaceXAI Can't Split, Arbitrate Slowdown Suit

    Artificial intelligence users urged a California federal judge Tuesday not to let SpaceXAI separate itself from their proposed class action accusing it, Anthropic, OpenAI and Google of violating antitrust law through their "pace the frontier" collaboration slowing down AI development, attacking the Elon Musk-owned company's efforts to invoke arbitration.

  • October 27, 2026

    Courts Take On Lilly GLP-1 Ads, J&J Mesothelioma Trial, More

    Law360 Healthcare Authority looks at a Novo Nordisk loss in its challenge to Eli Lilly's GLP-1 advertising, an Ohio verdict in wrongful death litigation over Johnson & Johnson's talc baby powder and other legal news from the past week.

  • October 27, 2026

    Daily Mail, Publishers Fight Google's 'Multi-Year Delay'

    Gannett, the Daily Mail and a certified class of website publishers urged a New York federal judge Monday not to let Google pause a scheduled advertising placement technology trial, arguing in twin briefs that the U.S. Department of Justice's antitrust win is strong and Google's appeal won't disrupt the multidistrict litigation.

  • October 27, 2026

    Disney Says Fubo Can't Appeal Arbitration Order

    Disney has asked a California federal court to deny Fubo subscribers certification of an interlocutory appeal as they fight an order to arbitrate their case over streaming rates, saying they failed to satisfy the requirements for it.

  • October 27, 2026

    ​​​​​​​Drugmakers Seek To Bar 'Big Pharma' Label In Price-Fix Trial

    A group of generic-drug makers facing price-fixing claims brought by dozens of state attorneys general asked a Connecticut federal judge to bar or limit the use of terms like "Big Pharma" or "rising costs of pharmaceuticals and healthcare" in next year's trial.

  • October 27, 2026

    Playground Equipment Makers Abandon Deal After FTC Action

    PlayPower has abandoned its planned purchase of fellow private equity-backed playground equipment maker BCI Burke after the Federal Trade Commission and a dozen states moved to challenge the deal.

  • October 27, 2026

    CMA Seeks Views On Prologis' £14B Segro Deal

    The antitrust regulator called Tuesday for input on how U.S. warehouse business Prologis' £14 billion ($19 billion) planned acquisition of British rival Segro might harm competition in U.K. markets.

  • October 27, 2026

    Amazon Can Seek Seller Evidence In £2.7B Data Misuse Claim

    Amazon can approach sellers for evidence to fight a £2.7 billion ($3.6 million) class action over alleged competition abuses, but a tribunal said the technology giant must inform them that refusing to cooperate will not jeopardize their business relationship.

  • October 26, 2026

    Google Says DOJ Overreaching With Proposed Antitrust Fixes

    Google has told a D.C. federal court that the U.S. Department of Justice and state enforcers are trying to force it into unreasonable antitrust measures that go beyond what the court imagined when it handed down its remedies order in the monopolization suit.

  • October 26, 2026

    Novo Can't Get 'Deceptive' Lilly GLP-1 Ads Blocked Amid Suit

    A New Jersey federal judge on Monday refused to issue an injunction blocking Eli Lilly & Co. from running ads allegedly comparing its GLP-1 drug to Novo Nordisk Inc.'s using "outdated" clinical trials and "false superiority messages," ruling that Novo Nordisk hasn't shown it would be irreparably harmed.

  • October 26, 2026

    Attys Seek $20M Award For $59M Fragrance Price-Fix Deals

    Fragrance ingredient buyers and the attorneys who helped them secure $59 million in price-fixing settlements are now asking a New Jersey federal court for final approval and the green light to set aside a third of those funds for legal counsel.

  • October 26, 2026

    Data-Scraping Co. Says Reddit Must Face Counterclaims

    A data-scraping company accused of acting like "would-be bank robbers" in taking in copyrighted data from Reddit that is then used to train AI said in a brief defending its antitrust counterclaims that the content in question actually belongs to Reddit users, and that Reddit anticompetitively restricts access to it.

  • October 26, 2026

    Blue Cross Says National TM Link Dooms Ford Antitrust Suit

    Blue Cross Blue Shield of Michigan and the Blue Cross Blue Shield Association have asked a Michigan federal judge to hand them a win in Ford Motor's antitrust suit alleging supracompetitive pricing, arguing the Blue Cross trademark means the association and affiliates act as a "single entity" that "cannot conspire with itself."

  • October 26, 2026

    NCAA Fixes Labor Price With DIII Scholarship Ban, Suit Says

    The NCAA engages in an ongoing conspiracy to fix the price of Division III athletic labor by not allowing colleges at that level to offer sports scholarships, three current and former student-athletes alleged in a proposed class action filed Friday in California federal court.

  • October 26, 2026

    Judge Reopens NC State Player's NCAA Eligibility Suit

    A federal judge reopened a North Carolina State University football player's eligibility suit against the NCAA on Monday after the player's attorneys informed the court that they have been unable to fully resolve the case.

  • October 26, 2026

    Comcast, Viamedia Settle Cable Ad Antitrust Case Before Trial

    Comcast Corp. and Viamedia Inc. have reached a settlement in their decadelong antitrust battle over the cable advertising market just days before a jury trial was set to begin in Illinois federal court over allegations the cable giant is monopolizing local advertising markets.

  • October 26, 2026

    In 2/3 Generics Cases, Mylan Execs Allowed To Revoke 5th

    A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.

  • October 26, 2026

    Ski Resorts, Trade Group Ask To Toss Price-Fixing Claims

    Major ski resort operators including Vail Resorts Inc. and Alterra Mountain Co. are looking to toss an antitrust case from skiers and snowboarders, telling a Colorado federal court there's no evidence the operators agreed to share information or fix prices.

  • October 26, 2026

    Charter Says AT&T's Fiber False Advertising Suit Is Baseless

    Charter Communications Inc. asked a Texas federal court to toss claims brought by AT&T Teleholdings Inc. accusing Charter of falsely touting its Spectrum-brand residential internet service as being entirely fiber, saying its advertisements of "fiber-powered" internet are not misleading.

  • October 26, 2026

    Bristol-Myers, Others Appeal Revlimid MDL To 3rd Circ.

    Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies have sought permission to file an interlocutory appeal for a sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid to the Third Circuit after a New Jersey federal judge refused to toss it.

  • October 26, 2026

    Colo. Real Estate Co. Says Investor Misread PE Priority Deal

    A Colorado industrial real estate firm seeking to exit a state court lawsuit argued that an investor retained its share in the company without scrutinizing a 2023 deal that gave a private equity firm control of the company and a priority stake in exchange for a $26.5 million investment.

  • October 26, 2026

    Govia Wins £7.6M Costs Deal After Rail Class Action Fails

    The Competition Appeal Tribunal approved a £7.6 million ($10.2 million) costs settlement in favor of Govia Thameslink Railway and its parent companies on Monday following the collapse of a £400 million collective action brought by the late David Boyle.

  • October 26, 2026

    Catching Up With Delaware's Chancery Court

    The Delaware Chancery Court last week approved a $250 million settlement of litigation over Microsoft Corp.'s acquisition of Activision Blizzard Inc., while Albertsons Cos. Inc. accused Kroger Co. of rejecting changes that could have saved their $24.6 billion merger, and the Delaware Supreme Court ordered Verisk Analytics Inc. to keep pursuing a $2.35 billion acquisition.

Expert Analysis

  • What To Know As DOJ Antitrust Biz Review Letters Return

    Author Photo

    The revival of the U.S. Department of Justice Antitrust Division's business letter review program reflects a trend of engagement with the business community, but the program's value will depend on the government's response speed, depth of analysis and ability to provide meaningful practical guidance, say attorneys at MoFo.

  • Series

    Going To Hardcore Shows Makes Me A Better Lawyer

    Author Photo

    While government contracts law and the hardcore scene may seem entirely unrelated, in my experience, both are about community, focus, being prepared for the unexpected and managing chaos, says Isaac Natter at Fluet.

  • Avoiding Sponsor Conflicts As NCAA Patch Rule Takes Effect

    Author Photo

    A new rule allowing schools to add corporate sponsor patches to athletes' uniforms may create a conflict with students' individual name, image and likeness agreements with competing brands, requiring negotiated contract provisions to reduce the legal risks, says Evan Rosenberg at Morritt Hock.  

  • 5 Antitrust Lessons On Bundled Discounts After Medtronic

    Author Photo

    The recent California federal court decision upholding a $381.7 million verdict against Medtronic offers practitioners a clearer road map for navigating bundled discount claims under Section 2 of the Sherman Act, and the practical implications are substantial, say attorneys at Norton Rose.

  • Justices' FTC Ruling Weakens Qui Tam's Constitutional Base

    Author Photo

    The U.S. Supreme Court’s holding in Trump v. Slaughter, expanding presidential control over those exercising executive power, suggests that courts may be receptive to arguments challenging the constitutional foundations of the False Claims Act’s qui tam mechanism, says Daniel Passeser at Wiggin.

  • FTC-Deere Deal Tells Cautionary Tale On Repair Access Limits

    Author Photo

    A recent proposed Federal Trade Commission antitrust settlement in Illinois federal court requires Deere & Co. to provide access to repair services previously available only to authorized dealers, and companies that limit access to aftermarket resources should ensure they can substantiate the reasoning behind any restrictions, say attorneys at Freshfields.

  • Series

    Being A Sommelier Makes Me A Better Lawyer

    Author Photo

    Being a sommelier has quietly shaped how I practice law by changing the way I think, communicate and connect with people, and offers a constant reminder that expertise is about making your knowledge useful and accessible to others, says Kara Du at Sheppard.

  • Card Grading Merger Suit Tests Antitrust In Niche Market

    Author Photo

    Rasmussen v. Collectors Holdings, a class action pending in California federal court challenging the effects of a trading card grading company merger, reflects the elevation of trading cards from hobby collectibles to niche investment markets susceptible to classic antitrust injury theories, say attorneys at Kean Miller.

  • Why A Class Was Certified In Financial Aid Info-Sharing Case

    Author Photo

    The recent Illinois federal court decision in Corzo v. Brown University offers key guidance for defendants confronting class certification in antitrust matters, highlighting how typicality can be satisfied despite class members attending different universities, receiving different aid awards and being affected across different time periods, say attorneys at Baker McKenzie.

  • FTC Focus: Enforcing Vertically Integrated Operating Systems

    Author Photo

    As digital platforms increasingly pair operating systems with commerce, advertising, content and data, antitrust scrutiny will turn on whether those integrations create private bottlenecks that foreclose rivals through access, ranking, interoperability or defaults, pushing courts and enforcement agencies to adapt traditional utility and merger frameworks more aggressively, say attorneys at Proskauer.

  • China's New Outbound Investment Rule Reshapes Deal Risk

    Author Photo

    China's new outbound investment regulation introduces broad national security review and penalties, including personal liability, that will necessitate deeper diligence of cross-border deal participants with Chinese ties, earlier regulatory planning and closer attention to sanctions exposure, say attorneys at Freshfields.

  • A Shift In How Policymakers Are Approaching PBM Regulation

    Author Photo

    Recent federal and state legislative and regulatory activity involving pharmacy benefit managers represent a change in focus from transparency to PBM compensation structures, vertical integration and competitive effects, say attorneys at Barclay Damon.

  • How State Actions Are Reshaping Surveillance Pricing Risk

    Author Photo

    Amid heightened state enforcement activity and expanding legislative action to curb surveillance pricing concerns related to transparency, fairness and discrimination, businesses should closely examine how consumer data is used in pricing decisions, say attorneys at Steptoe.

  • Opinion

    States Should Reconsider Forced PBM Divestiture Laws

    Author Photo

    State legislatures are attempting to enact policies intended to force pharmacy benefit managers to divest from pharmacies, but these laws would have the practical effect of reducing patient access and competition, potentially violating the U.S. Constitution in the process, says former Utah Attorney General John Swallow.

  • HSR Deals Proceed More Steadily Than Narratives Suggest

    Author Photo

    The most recent Hart-Scott-Rodino Act data show that transaction volume remained relatively stable, transaction values continued to increase and enforcement activity remained low, suggesting that enforcement rates have been relatively consistent across presidential administrations despite widely differing public rhetoric regarding merger enforcement, says Amanda Wait at Michael Best.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.